Today is Thursday, Sep. 24, 2020

Department of Internal Medicine

Hematology & Oncology

Photo of Jennifer Leddon, MD, PhD

Jennifer Leddon, MD, PhD

Research Interests

Tumor immunology and immunotherapies

  • MD/PhD: University of Cincinnati
  • BS: University of Alabama
Contact Information

Peer Reviewed Publications

No Publications found

Abstract Publications

Leddon, J.L., Chen, C.Y., Currier, M.A., Wang, P.Y., Jung, F.A., Denton, N.L., Cripe, K.M., Haworth, K.B., Arnold, M.A., Gross, A.C. and Eubank, T.D. 2015. Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity Molecular therapy oncolytics, 1 , 14010

Currier, M.A., Eshun, F.K., Sholl, A., Chernoguz, A., Crawford, K., Divanovic, S., Boon, L., Goins, W.F., Frischer, J.S., Collins, M.H. and Leddon, J.L. 2013. VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells Molecular Therapy, 21(5) , 1014

Browne, A.W., Leddon, J.L., Currier, M.A., Williams, J.P., Frischer, J.S., Collins, M.H., Ahn, C.H. and Cripe, T.P. 2011. Cancer screening by systemic administration of a gene delivery vector encoding tumor-selective secretable biomarker expression PloS one, 6(5) , 19530